FierceBiotechFierceBiotechResearchFierceBiotechITFierceVaccinesFiercePharmaFiercePharmaManufacturing   FierceHealthcare

Free Newsletter

About | View Sample | Privacy
Related Topics >> Pravachol | Zocor | Lipitor | AstraZeneca

Sleep study could boost some statins

Tools

If simvastatin (Zocor) can cause insomnia and nightmares as a new study shows, then why doesn't pravastatin (Pravachol)? It seems that Zocor and its rivals Lipitor, Mevacor, and Vytorin are fat soluble, and so they cross into the brain easily. Pravachol, Crestor, and Lescol which are water-soluble, don't.

So perhaps AstraZeneca can latch onto this study as a marketing tool for Crestor, since it lost out with its big heart failure study earlier this week. You'll recall that the company's CORONA project, intended to show that Crestor could help patients with heart failure, didn't exactly deliver. Too bad Lipitor is on the Zocor side of the insomnia divide. A good night's sleep could have been a selling point for the Pfizer blockbuster, which has been losing patients to the newly generic simvastatin by the thousands.

- see the American Heart Association release
- check out this report
- read more about the way statins sneak into the brain from WebMD

Related Articles:
Tossing and turning? Maybe it's the Zocor
Zocor feeling the heat from generics
AZ's Crestor flubs key heart failure trial
Switching to generic statins not so healthy

Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FiercePharma Email Newsletter:
Be the first to comment
More stories about Zocor   Lipitor   AstraZeneca   Pravachol  

Comments

Post new comment

The content of this field is kept private and will not be shown publicly.

More information about formatting options

To combat spam, please enter the code in the image.